Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Diabetic and ER-stressed pancreatic islet β cells are in need of some JNK removal
Jonathan M. Palozzi, Pere Puigserver
Jonathan M. Palozzi, Pere Puigserver
View: Text | PDF
Commentary

Diabetic and ER-stressed pancreatic islet β cells are in need of some JNK removal

  • Text
  • PDF
Abstract

Pancreatic β cells regulate glucose homeostasis through insulin secretion, but nutrient overload and genetic defects can trigger ER stress and apoptosis, contributing to type 2 diabetes. Within β cells, the kinases PERK, IRE1α, and ATF6 initiate the unfolded protein response (UPR) as a result of ER stress, a process that is constitutively suppressed under nonstress conditions by GRP78 binding to these proteins. To gain insight into the mechanisms of β cell death upon dysregulated ER stress, Sharma et al. used β cell–specific GRP78 knockout models, revealing that hyperactivation of the UPR promoted β cell death primarily through the IRE1α/JNK/p53 signaling pathway. Pharmacological inhibition of JNK improved β cell survival, increased insulin levels, and lowered blood glucose in multiple diabetic mouse models. These findings highlight JNK signaling as a promising therapeutic target for preserving β cell function.

Authors

Jonathan M. Palozzi, Pere Puigserver

×

Figure 1

Pharmacological inhibition of the IRE1α-JNK-p53 signaling axis suppresses islet β cell death.

Options: View larger image (or click on image) Download as PowerPoint
Pharmacological inhibition of the IRE1α-JNK-p53 signaling axis suppresse...
Insulin is produced in the ER of islet β cells and is secreted to regulate circulating glucose. Dysregulation of ER stress in islet β cells can be induced by genetic factors or dietary factors, like overnutrition, leading to loss of β cell mass and impairments in insulin secretion and glucose homeostasis. (A) Under nonstressed conditions, GRP78 constitutively suppresses dimerization of IRE1α, inhibiting activation of the UPR pathway. (B) In Sharma et al.’s study (16), β cell–selective depletion of Grp78 permitted dimerization and activation of the stress kinase IRE1α, which, in turn, phosphorylated JNK, activated p53, and led to apoptosis. Systemic application of pharmacological inhibitors targeting any step in this process reduced β cell death, increased insulin secretion, and had an antidiabetic effect in these mice.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts